Varahi Pharma Profile
Key Indicators
- Authorised Capital ₹ 11.30 Cr
as on 16-06-2024
- Paid Up Capital ₹ 11.23 Cr
as on 16-06-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.13 Cr
as on 16-06-2024
- Satisfied Charges ₹ 25.87 Cr
as on 16-06-2024
- Revenue 45.90%
(FY 2021)
- Profit 376.23%
(FY 2021)
- Ebitda -57.56%
(FY 2021)
- Net Worth 2.02%
(FY 2021)
- Total Assets 0.70%
(FY 2021)
About Varahi Pharma
The Corporate was formerly known as Varahi Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 11.30 Cr and a paid-up capital of Rs 11.23 Cr.
The company currently has active open charges totaling ₹4.13 Cr. The company has closed loans amounting to ₹25.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paresh Jani, Gangula Suresh, Shekhar Gangula, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24297TG2010PTC066811
- Company No.
066811
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2010
- Date of AGM
30 Sep 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Varahi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Vasudevan  | Managing Director | 12-Jul-2014 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paresh Jani | Director | Current | |
| Gangula Suresh | Director | 16-Aug-2014 | Current |
| Shekhar Gangula | Director | 12-Jul-2014 | Current |
| Jayarami Sakam | Director | 13-Aug-2012 | Current |
Financial Performance and Corporate Structure Insights of Varahi Pharma.
Varahi Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 45.9% increase. The company also saw a substantial improvement in profitability, with a 376.23% increase in profit. The company's net worth moved up by a moderate rise of 2.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Varahi Pharma?
In 2021, Varahi Pharma had a promoter holding of 38.64% and a public holding of 61.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Mar 2019 | ₹4.00 Cr | Open |
Others Creation Date: 25 Jun 2018 | ₹1.30 M | Open |
Hdfc Bank Limited Creation Date: 29 Dec 2018 | ₹12.57 Cr | Satisfied |
How Many Employees Work at Varahi Pharma?
Varahi Pharma has a workforce of 44 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varahi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varahi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
